News

Compass Therapeutics Set to Showcase at Key Healthcare Event

Compass Therapeutics Set to Showcase at Key Healthcare Event

Compass Therapeutics Gears Up for Major Healthcare Conference

BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), known for its innovative approach toward developing antibody-based therapeutics for oncology, is preparing to present at the prestigious J.P. Morgan 2026 Healthcare Conference. This event, scheduled for January 14, 2026, will serve as a pivotal moment for the company as it seeks to engage with potential investors and showcase its advancements in clinical-stage therapies.

Details of the Presentation

The presentation at the J.P. Morgan Healthcare Conference is set to begin at 7:30 AM PT. Attendees will have the opportunity to gain insights into Compass Therapeutics' ongoing research and development initiatives. This presentation is anticipated to highlight the latest advancements in therapeutic strategies and results related to their unique product candidates.

Accessing the Event

For those unable to attend the live presentation, a recorded version will be made available afterwards. Investors can find this on Compass’ events page, ensuring that they remain updated on the company's progress even if they miss the live session.

Investor Engagement Opportunities

On January 14, 2026, Compass Therapeutics invites interested investors to arrange one-on-one meetings with key company representatives, facilitating a more personalized discussion regarding their innovative pipeline and future plans. This meeting offers a unique platform for investors to dive deeper into Compass’ development projects and strategic vision.

Participation in LifeSci Partners Corporate Access Event

In addition to showcasing at the J.P. Morgan conference, Compass Therapeutics is also scheduled to participate in the LifeSci Partners Corporate Access Event on January 12 and 13, 2026. This event, taking place in San Francisco, CA, represents another strategic opportunity for Compass Therapeutics to connect with investors and stakeholders, laying the foundation for fruitful relationships moving forward.

About Compass Therapeutics

Founded in 2014, Compass Therapeutics is driven by the quest to create effective therapeutic solutions to combat human diseases, particularly in the oncology space. The company’s core focus revolves around understanding the complex interactions between angiogenesis, the immune system, and tumor growth, paving the way for the development of novel treatments. Their robust pipeline features multiple promising product candidates designed to engage crucial biological pathways essential for an effective anti-tumor response, including innovative methods to counteract tumoral defenses that hinder immune surveillance.

The Company’s Vision

Compass Therapeutics envisions moving its product candidates through rigorous clinical trials, either as standalone therapies or in synergy with other proprietary antibodies. This dual-approach empowers the company to leverage both established therapies and emerging treatment paradigms to enhance patient outcomes.

Leadership and Expertise

With a team comprised of leading experts in biotechnology, Compass Therapeutics is harnessing their collective expertise to propel the company’s mission. Their collaborative environment is optimized for developing groundbreaking therapeutic solutions aimed at challenging diseases thought to be difficult to treat.

Contact Information

Those interested in learning more about Compass Therapeutics or scheduling meetings during the upcoming conferences can reach out via the following channels: for investor inquiries, please contact ir@compasstherapeutics.com, and for media inquiries, reach out to Anna Gifford, Chief of Staff, at media@compasstherapeutics.com or call 617-500-8099.

Frequently Asked Questions

What is Compass Therapeutics?

Compass Therapeutics is a biopharmaceutical company focusing on oncology through the development of antibody-based therapeutics.

When will Compass present at the J.P. Morgan Healthcare Conference?

Compass Therapeutics will present on January 14, 2026, at 7:30 AM PT.

How can investors participate in meetings with Compass?

Investors can arrange one-on-one meetings by contacting their J.P. Morgan representative on January 14, 2026.

What are the key areas of focus for Compass Therapeutics?

The company is focused on the relationship between angiogenesis, immune response, and tumor growth, aiming to create effective cancer treatments.

Where can I find more information about Compass Therapeutics?

For more details, visit the official Compass Therapeutics website at https://www.compasstherapeutics.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Senior Care's Future: AI and Expert Insights Collide

Updated Category News Views 0

The Inflection Point in Senior Care We’re standing at a crossroads, folks. The senior care industry is feeling the pressure from all sides: a growing aging population, relentless staffing shortages, and increasing demands for transparency. So, what do you do when you're trying to keep a sinking ship afloat? Well, Sensi.AI reckons it’s time to call in the big guns. A...

Continue Reading
Quandri Joins Applied Systems Certification for AI Edge

Updated Category News Views 0

Quandri Steps Into the Limelight with Vendor Certification Alright, so you’ve got Quandri, an up-and-coming player on the insurance tech scene, making some hefty strides by snatching a coveted spot in Applied Systems' brand new Vendor Certification Program. Yeah, it sounds like another day at the software club, but what this really means is less runaround and more...

Continue Reading
Vimi Wellness and Goodan: A Fusion of Women's Healing

Updated Category News Views 9

Crossing Continents for Women's Healing When Chelsey Goodan, an American expert in adolescent education, made her way to Hangzhou, China, it wasn't just another stop on her world tour. No, this was her first venture into China, rallying with Zhang Xinyuan, the brains behind Vimi Wellness. For those not in the know, Vimi's been pioneering women's intimate health and...

Continue Reading
Nozomi Networks: Leading OT Security in 2026

Updated Category News Views 1

One Year of Massive Wins for Nozomi Networks Here's a wild trajectory: Nozomi Networks has been firing on all cylinders in 2026, capturing attention not just from analysts but also from anyone with a stake in the security game. The company’s impressive run was highlighted most recently when they were crowned a Leader in The Forrester Wave: Operational Technology...

Continue Reading
SecondSideMedia Tackles AI Misinformation with New Platform

Updated Category News Views 3

Overcoming the AI Misinformation Maze The AI revolution isn't without its hiccups, and when machines spin their tales wrong, damage control becomes a necessity. Enter SecondSideMedia, coming out swinging with a platform specifically crafted to tackle those pesky inaccuracies AI can spit out. They launched this beauty after a successful pilot and they aren't following the...

Continue Reading
Syra Health Expands Public Health Wellness Initiative

Updated Category News Views 0

Wellness Programs in Public Health: A Necessary Evolution Syra Health and Wake County Public Health are kicking off a renewed push for wellness with their Wellness S.P.A. 2.0 initiative. This isn't just a fancy rehash of their earlier project. Nope, it's a full-on effort to support those on the frontline of public health, those folks bearing the brunt of complex...

Continue Reading
American Tungsten's Bold Play in Nevada is Noteworthy

Updated Category News Views 1

American Tungsten's Shifting Focus Today we're chewing over some intriguing moves from American Tungsten & Antimony, Ltd. (ASX: AT4; OTCQX: ATALF). These cats are eyeing a chunk of the strategic metals market. They've engaged Metso Finland Oy to whip up a Scoping Study for an ammonium paratungstate (APT) production circuit at their Del Sol Refinery in Nevada. Why Tungsten...

Continue Reading
PrimeBOT Unveils Game-Changing Robots at IFA 2026

Updated Category News Views 7

PrimeBOT Ushers in a New Era of Personal Robotics Bodies and brains made of metal marching into the future—no, it's not science fiction, it's PrimeBOT at IFA 2026. PrimeBOT is rolling out two head-turning robots, the PrimeBOT T1 and PrimeBOT Q1, with ambitions to infiltrate our daily lives. The company's vision for 'Creating a Better Life through Embodied Intelligence'...

Continue Reading
HUMAIN & Reflection's Bold AI Move at LEAP 2026

Updated Category News Views 10

AI's Next Chapter Unveiled in Riyadh You ever watch two titans come together and think, this could either change the game or just be another flash in the pan? That's where we are as HUMAIN and Reflection AI are jumping into bed at LEAP 2026 in Riyadh. They're not kidding around with their plans to deploy Reflection's AI models on HUMAIN's infrastructure by year's end....

Continue Reading
HiTHIUM Surges in Global Energy Storage Battle

Updated Category News Views 3

Man, those aren't small potatoes in the energy storage realm! HiTHIUM’s blitz on the global rankings has caught my eye, and I don’t toss around praise lightly. The news out of Xiamen is that HiTHIUM secured the number two spot globally in energy storage battery shipments once again. That’s not just a medal; it’s a flashing beacon in a sector skyrocketing faster...

Continue Reading

Top 5 Most Recently Viewed Articles

Nokia Corporation Highlights Managerial Share Transactions

Updated Category News Views 235

Nokia Corporation Highlights Managerial Share Transactions Nokia Corporation has made headlines recently as it announced critical managerial transactions involving share-based incentives. This notification, which falls under Article 19 of the EU Market Abuse Regulation, showcases the company’s transparency and commitment to adhering to regulations. Understanding the...

Continue Reading
Ondine Biomedical Secures $11M for Phase 3 Clinical Trial Launch

Updated Category News Views 83

Ondine Biomedical's Significant Fundraising Milestone Ondine Biomedical, a promising Canadian life sciences company, has recently made headlines by securing Cdn $16 million (approximately US $11 million) in funding. This financial infusion is set to propel the company towards the launch of its pivotal Phase 3 clinical trial in the U.S., aimed for a start in the fourth...

Continue Reading
2026 Insights: A Promising Future for Americas Real Estate

Updated Category News Views 206

2026 Insights into Americas Real Estate Dynamics The Americas real estate sector is on the verge of breaking away from its repetitive cycles, as outlined in the recent Insights, Strategy and Analysis (ISA) Outlook report published by LaSalle Investment Management. The conditions in 2026 are set to differ markedly from those of the past few years, with signs indicating a...

Continue Reading
Investors Show Strength in Amazon.com Options Trading

Updated Category News Views 166

Smart Money Moves in Amazon Options Investors willing to invest heavily have taken a bullish position on Amazon.com (NASDAQ: AMZN). This signals a notable interest in the company's future, one that retail traders should consider. Such actions don't go unnoticed in the market, especially when there are substantial trades showing up in the publicly accessible options...

Continue Reading
Western Star's Crucial Move in Tungsten Race

Updated Category News Views 2

Tungsten Race Heats Up: A Strategic Move by Western Star It might not be flashy, but Western Star's latest maneuver could have big implications for the tungsten supply chain, especially in the U.S. defense sector. With the clock ticking towards a 2027 deadline to restrict Chinese tungsten imports, the stakes have grown higher than ever. Western Star Resources Inc. (CSE:...

Continue Reading